EPISODE · Apr 27, 2026 · 10 MIN
JCO Article Insights: LEAP-010 Study in Recurrent/Metastatic Head and Neck Cancer
from Journal of Clinical Oncology (JCO) Podcast
Host Jake New summarizes and offers insights into the JCO article by Licitra et al., "Pembrolizumab With or Without Lenvatinib as First-Line Therapy for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: Phase III LEAP-010 Study." LINK TO FULL TRANSCRIPT
NOW PLAYING
JCO Article Insights: LEAP-010 Study in Recurrent/Metastatic Head and Neck Cancer
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m